Status:
UNKNOWN
Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients
Lead Sponsor:
Seoul National University Hospital
Conditions:
Delirium
Eligibility:
All Genders
19-90 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy of low dose quetiapine for the prophylaxis of delirium in critically ill patients in medical intensive care unit.
Eligibility Criteria
Inclusion
- Greater than or equal to 19 years of age, admitting to medical ICU, anticipated to stay more than 72hours
Exclusion
- Female patients who are pregnant or breastfeeding
- active delirium
- Received other anti-psychotic drug before attend the study
- severe bradycardia
- alcohol intoxication
- No written consent from the legal representatives
- Being ill with renal or hepatic failure
Key Trial Info
Start Date :
March 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT02297763
Start Date
March 1 2015
Last Update
November 21 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.